» Articles » PMID: 36365125

Films, Gels and Electrospun Fibers from Serum Albumin Globular Protein for Medical Device Coating, Biomolecule Delivery and Regenerative Engineering

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Nov 11
PMID 36365125
Authors
Affiliations
Soon will be listed here.
Abstract

Albumin is a natural biomaterial that is abundantly available in blood and body fluids. It is clinically used as a plasma expander, thereby increasing the plasma thiol concentration due to its cysteine residues. Albumin is a regulator of intervascular oncotic pressure, serves as an anti-inflammatory modulator, and it has a buffering role due to its histidine imidazole residues. Because of its unique biological and physical properties, albumin has also emerged as a suitable biomaterial for coating implantable devices, for cell and drug delivery, and as a scaffold for tissue engineering and regenerative medicine. As a biomaterial, albumin can be used as surface-modifying film or processed either as cross-linked protein gels or as electrospun fibers. Herein we have discussed how albumin protein can be utilized in regenerative medicine as a hydrogel and as a fibrous mat for a diverse role in successfully delivering drugs, genes, and cells to targeted tissues and organs. The review of prior studies indicated that albumin is a tunable biomaterial from which different types of scaffolds with mechanical properties adjustable for various biomedical applications can be fabricated. Based on the progress made to date, we concluded that albumin-based device coatings, delivery of drugs, genes, and cells are promising strategies in regenerative and personalized medicine.

Citing Articles

Research progress on albumin-based hydrogels: Properties, preparation methods, types and its application for antitumor-drug delivery and tissue engineering.

Meng R, Zhu H, Deng P, Li M, Ji Q, He H Front Bioeng Biotechnol. 2023; 11:1137145.

PMID: 37113668 PMC: 10127125. DOI: 10.3389/fbioe.2023.1137145.


Laser Ablated Albumin Functionalized Spherical Gold Nanoparticles Indicated for Stem Cell Tracking.

Dziedzic D, Mogharbel B, Irioda A, Stricker P, Woiski T, Machado T Materials (Basel). 2023; 16(3).

PMID: 36770041 PMC: 9919444. DOI: 10.3390/ma16031034.

References
1.
Schnitzer J, Oh P . Antibodies to SPARC inhibit albumin binding to SPARC, gp60, and microvascular endothelium. Am J Physiol. 1992; 263(6 Pt 2):H1872-9. DOI: 10.1152/ajpheart.1992.263.6.H1872. View

2.
Carpena N, Abueva C, Padalhin A, Lee B . Evaluation of egg white ovomucin-based porous scaffold as an implantable biomaterial for tissue engineering. J Biomed Mater Res B Appl Biomater. 2016; 105(7):2107-2117. DOI: 10.1002/jbm.b.33750. View

3.
Wartlick H, Spankuch-Schmitt B, Strebhardt K, Kreuter J, Langer K . Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles. J Control Release. 2004; 96(3):483-95. DOI: 10.1016/j.jconrel.2004.01.029. View

4.
Sebak S, Mirzaei M, Malhotra M, Kulamarva A, Prakash S . Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis. Int J Nanomedicine. 2010; 5:525-32. PMC: 2948945. DOI: 10.2147/ijn.s10443. View

5.
Martin M, Pfaffen V, Valenti L, Giacomelli C . Albumin biofunctionalization to minimize the Staphylococcus aureus adhesion on solid substrates. Colloids Surf B Biointerfaces. 2018; 167:156-164. DOI: 10.1016/j.colsurfb.2018.04.006. View